Philips announced the main terms of an agreement it reached in January with the U.S. government on its new sleep apnea ...

Philips (NYSE: PHG) today announced a final agreement on a consent decree with the FDA and U.S. Dept. of Justice (DOJ).

A U.S. federal court has officially ordered Philips to restrict the production and sale of its CPAP and BiPAP ventilators for ...

Philips said the costs of the consent decree led to a provision of 363 million euros in the fourth quarter of 2023, and were ...

Under the consent decree, Philips (PHG) Respironics will continue to prioritize completing the remediation of the sleep and respiratory care devices under its voluntary 2021 recall. Philips (PHG ...

Federal Court Enters Consent Decree Against Philips Respironics Following Recall of Certain Sleep Therapy Machines ...

Subsidiaries of Philips, Philips Holding USA and Philips Respironics, agreed with the Justice Department and FDA's consent decree. The company also agreed with the recall remediation plan, which ...

Philips Respironics will retain independent experts to review various aspects of the recall remediation ... to be used in accordance with the instructions for use. Roy Jakobs, CEO at Philips said: ...

CEO Roy Jakobs in January noted on ... Under the terms of the agreement, Philips Respironics will continue the recall. The company said that more than 99% of the sleep therapy devices have been ...

The decree also requires implementation of a Recall Remediation Plan, agreed to by the FDA and Philips Respironics, to help ensure relief is provided to patients impacted by Philips Respironics ...